rs535286672
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_198576.4(AGRN):c.4879+17T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000479 in 859,976 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0016 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00028 ( 1 hom. )
Consequence
AGRN
NM_198576.4 intron
NM_198576.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.260
Publications
0 publications found
Genes affected
AGRN (HGNC:329): (agrin) This gene encodes one of several proteins that are critical in the development of the neuromuscular junction (NMJ), as identified in mouse knock-out studies. The encoded protein contains several laminin G, Kazal type serine protease inhibitor, and epidermal growth factor domains. Additional post-translational modifications occur to add glycosaminoglycans and disulfide bonds. In one family with congenital myasthenic syndrome affecting limb-girdle muscles, a mutation in this gene was found. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2015]
AGRN Gene-Disease associations (from GenCC):
- congenital myasthenic syndrome 8Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- presynaptic congenital myasthenic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- postsynaptic congenital myasthenic syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 1-1050054-T-A is Benign according to our data. Variant chr1-1050054-T-A is described in ClinVar as Likely_benign. ClinVar VariationId is 263190.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00161 (206/127868) while in subpopulation AFR AF = 0.00642 (191/29768). AF 95% confidence interval is 0.00567. There are 2 homozygotes in GnomAd4. There are 98 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| AGRN | ENST00000379370.7 | c.4879+17T>A | intron_variant | Intron 27 of 35 | 1 | NM_198576.4 | ENSP00000368678.2 | |||
| AGRN | ENST00000651234.1 | c.4564+17T>A | intron_variant | Intron 26 of 37 | ENSP00000499046.1 | |||||
| AGRN | ENST00000652369.2 | c.4564+17T>A | intron_variant | Intron 26 of 34 | ENSP00000498543.1 | |||||
| AGRN | ENST00000620552.4 | c.4465+17T>A | intron_variant | Intron 27 of 38 | 5 | ENSP00000484607.1 |
Frequencies
GnomAD3 genomes AF: 0.00160 AC: 205AN: 127820Hom.: 2 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
205
AN:
127820
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000365 AC: 50AN: 137146 AF XY: 0.000281 show subpopulations
GnomAD2 exomes
AF:
AC:
50
AN:
137146
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000281 AC: 206AN: 732108Hom.: 1 Cov.: 32 AF XY: 0.000223 AC XY: 84AN XY: 376688 show subpopulations
GnomAD4 exome
AF:
AC:
206
AN:
732108
Hom.:
Cov.:
32
AF XY:
AC XY:
84
AN XY:
376688
show subpopulations
African (AFR)
AF:
AC:
153
AN:
12526
American (AMR)
AF:
AC:
15
AN:
31376
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
17116
East Asian (EAS)
AF:
AC:
0
AN:
20714
South Asian (SAS)
AF:
AC:
2
AN:
67286
European-Finnish (FIN)
AF:
AC:
0
AN:
33894
Middle Eastern (MID)
AF:
AC:
1
AN:
2656
European-Non Finnish (NFE)
AF:
AC:
0
AN:
515512
Other (OTH)
AF:
AC:
35
AN:
31028
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
9
18
28
37
46
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00161 AC: 206AN: 127868Hom.: 2 Cov.: 32 AF XY: 0.00158 AC XY: 98AN XY: 61920 show subpopulations
GnomAD4 genome
AF:
AC:
206
AN:
127868
Hom.:
Cov.:
32
AF XY:
AC XY:
98
AN XY:
61920
show subpopulations
African (AFR)
AF:
AC:
191
AN:
29768
American (AMR)
AF:
AC:
13
AN:
13412
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3220
East Asian (EAS)
AF:
AC:
0
AN:
3746
South Asian (SAS)
AF:
AC:
0
AN:
3700
European-Finnish (FIN)
AF:
AC:
0
AN:
8440
Middle Eastern (MID)
AF:
AC:
0
AN:
276
European-Non Finnish (NFE)
AF:
AC:
1
AN:
62646
Other (OTH)
AF:
AC:
1
AN:
1802
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.524
Heterozygous variant carriers
0
8
17
25
34
42
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Congenital myasthenic syndrome 8 Benign:1
Jan 24, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.